Literature DB >> 12075416

Analysis and Molecular Cloning of Differentially Expressing Genes in Nasopharyngeal Carcinoma.

Ying Yu1, Bi-Cheng Zhang, Yi Xie, Li Cao, Ming Zhou, Feng-Huang Zhan, Gui-Yuan Li.   

Abstract

In order to further examine expression of cDNA fragments isolated by cDNA representational difference analysis(cDNA RDA) in nasopharyngeal carcinoma(NPC) biopsies and to clone those deregulated genes associated with NPC, RT-PCR and Northern blot were used to identify the differentially expressed cDNA fragments in NPC biopsies and confirm the transcript length of those genes, then a full-length cDNA sequences was cloned and its product was analyzed by bioinformatics. The results showed that AF091521, AF091520, AF152605 and AF091517 cDNA sequences had distinct expression difference between primary cultural normal nasopharyngeal epithelial cell and NPC biopsies, and AF091521, AF091517 genes all had two transcripts whose sizes were 1.5, 2.3 and 1.1, 1.4 kb respectively, while AF091520 and AF152605 gene expressed one transcript only, respectively, whose sizes were 1.6 and 2.2 kb. An AF091517 EST gene, named as NAG11, (GenBank accession number AF170307) was isolated by sequencing one EST clone, which encoded a transmembrane protein of 88 amino acid including three protein ATP-binding regions, two protein kinase C phosphorylation sites and two N-myristoylation sites. So it is further demonstrated that NPC is a disease with multiple gene alterations NAG11 gene is a candidate of putative tumor suppressor genes associated with NPC, whose down-expression may be involved in the development of NPC and NAG11 gene product may play a role in the transmembrane transport of ATP.

Entities:  

Year:  2000        PMID: 12075416

Source DB:  PubMed          Journal:  Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)        ISSN: 0582-9879


  8 in total

1.  Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.

Authors:  Huaying Liu; Xiaoling Li; Zhaoxia Niu; Liming Zhang; Ming Zhou; He Huang; Jiajin He; Wenling Zhang; Lan Xiao; Yunlian Tang; Li Wang; Guiyuan Li
Journal:  J Histochem Cytochem       Date:  2007-12-10       Impact factor: 2.479

2.  BRD2 is one of BRD7-interacting proteins and its over-expression could initiate apoptosis.

Authors:  Ming Zhou; Xiao-Jie Xu; Hou-De Zhou; Hua-Ying Liu; Jia-Jin He; Xiao-Ling Li; Cong Peng; Wei Xiong; Song-Qing Fan; Jian-Hong Lu; Jue Ouyang; Shou-Rong Shen; Bo Xiang; Gui-Yuan Li
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

Review 3.  BRD7: a novel tumor suppressor gene in different cancers.

Authors:  Xin Yu; Zheng Li; Jianxiong Shen
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  BRD7 is a candidate tumour suppressor gene required for p53 function.

Authors:  Jarno Drost; Fiamma Mantovani; Francesca Tocco; Ran Elkon; Anna Comel; Henne Holstege; Ron Kerkhoven; Jos Jonkers; P Mathijs Voorhoeve; Reuven Agami; Giannino Del Sal
Journal:  Nat Cell Biol       Date:  2010-03-14       Impact factor: 28.824

5.  Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer.

Authors:  Xiao-Mei Zhang; Xiao-Yan Wang; Shou-Rong Sheng; Jie-Ru Wang; Jiang Li
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

6.  Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.

Authors:  Huaying Liu; Ming Zhou; Xiaomin Luo; Liming Zhang; Zhaoxia Niu; Cong Peng; Jian Ma; Shuping Peng; Houde Zhou; Bo Xiang; Xiayu Li; Shufang Li; Jiajin He; Xiaoling Li; Guiyuan Li
Journal:  BMC Mol Biol       Date:  2008-12-27       Impact factor: 2.946

7.  Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.

Authors:  Huaying Liu; Liming Zhang; Zhaoxia Niu; Ming Zhou; Cong Peng; Xiayu Li; Tan Deng; Lei Shi; Yixin Tan; Guiyuan Li
Journal:  BMC Cancer       Date:  2008-09-08       Impact factor: 4.430

8.  BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer.

Authors:  Weihong Niu; Yanwei Luo; Xinye Wang; Yao Zhou; Hui Li; Heran Wang; Yaojie Fu; Shanshan Liu; Shanghelin Yin; Jianglei Li; Ran Zhao; Yukun Liu; Songqing Fan; Zheng Li; Wei Xiong; Xiaoling Li; Guiyuan Li; Caiping Ren; Ming Tan; Ming Zhou
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.